The Latest in Diabetes

SGLT2 inhibitors have a breakout year

August 6, 2020

Diabetes

Unexpected rosuvastatin-canagliflozin adverse effect reported

August 4, 2020

Diabetes

COVID-19 taking financial toll on people in U.S. with diabetes

August 3, 2020

Diabetes

Real-world data show SGLT2 inhibitors for diabetes triple DKA risk

July 29, 2020

Diabetes

Dapagliflozin Improves Cardiovascular Outcomes in Patients With Heart Failure and Reduced Ejection Fraction

July 29, 2020

Diabetes

Part 5: Screening for “Opathies” in Diabetes Patients

July 28, 2020

Diabetes

Cleaner data confirm severe COVID-19 link to diabetes, hypertension

July 27, 2020

Diabetes

Part 4: Monitoring for CKD in Diabetes Patients

July 21, 2020

Diabetes

SGLT2 inhibitors, developed for T2D, now ‘belong to cardiologists and nephrologists’

July 16, 2020

Diabetes

Guidance addresses elders with diabetes during COVID-19

July 16, 2020

Diabetes

Novel program cuts weight retention after gestational diabetes

July 15, 2020

Diabetes

Good for profits, good for patients: A new form of medical visits

July 14, 2020

Diabetes

Part 3: Lipid Management in Diabetes Patients

July 14, 2020

Diabetes

Hyperglycemia predicts COVID-19 death even without diabetes

July 13, 2020

Diabetes

More proof that fruit, vegetables, whole grains may stop diabetes

July 10, 2020

Diabetes